Alberto J. Espay, MD, MSc, comments on the tension between viewing Parkinson's disease as unique to each patient and the prospect of universal treatments.
When it was prescribed within a week of SARS CoV-2 infection, metformin was associated with a 53% reduction in long COVID or ...
High-dose flu vaccinations resulted in a 23% reduction in hospitalizations among people aged 65 years or older, according to ...
As many as one in 14 patients suffer harm due to diagnostic errors while in hospital, and most of these could be prevented, a ...
Many people with cancer are interested in using cannabis for symptom management, but few talk to their doctor about it. ASCO ...
Politicians seek more involuntary treatment of homeless people with mental illness and addiction, but experts object to this ...
Tenecteplase was shown to be superior to alteplase for acute ischemic stroke, with a greater chance of excellent recovery and ...
The findings suggested that higher doses of vitamin D3 supplementation do not reduce markers of subclinical cardiovascular ...
Pediatric MG is rare. Cases in children are estimated to account for 10% of MG cases diagnosed each year. According to a 2020 ...
Researchers conducted a retrospective analysis to identify the specific population of patients with TNBC that benefited from ...
SAVANNAH, Georgia — A new clinical education tool aims to speed the diagnosis of amyotrophic lateral sclerosis (ALS), which ...
More than 90% of patients with PsA who received guselkumab every 8 weeks in the DISCOVER-2 trial maintained minimal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback